NCT04786964 2025-04-02
CONTERNO
Checkpoint Therapeutics, Inc.
Phase 3 Terminated
Checkpoint Therapeutics, Inc.
Calithera Biosciences, Inc
SCRI Development Innovations, LLC
National Institutes of Health Clinical Center (CC)
AHS Cancer Control Alberta
Case Comprehensive Cancer Center